跳至主要内容
临床试验/NCT05650151
NCT05650151尚未招募不适用

Peri-operative Vitamin D Therapy for Patients With Hepatocellular Carcinoma Receiving Hepatectomy

National Taiwan University Hospital0 个研究点目标入组 200 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
主要终点
Infection rate

研究概览

简要总结

The goal of this double-blind, randomized controlled trial is to test the effect of short-term and high-dose vitamin D therapy in patients undergoing hepatectomy for hepatocellular carcinoma.

详细描述

Participants will receive short-term high dose of vitamin D during perioperative period.

The main questions the study aims to answer are:

  1. If vitamin D therapy benefits perioperative care
  2. If short-term high dose of vitamin D supplement is safe

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 20 years
  • Patients will undergo hepatectomy for hepatocellular carcinoma.

排除标准

  • Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma

结局指标

主要结局

Infection rate

时间窗: Perioperative period

Diagnosed by clinical presentation and relevant biomarker

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Peri-operative Vitamin D Therapy for Hepatectomy | 临床试验